Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 938-695-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- between the 24th August and 13th December 2011
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Study conducted in compliance with agreed protocols, with no or minor deviations from standard test guidelines and/or minor methodological deficiencies, which do not affect the quality of relevant results.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 011
- Report date:
- 2011
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- PC-9S
- IUPAC Name:
- PC-9S
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
- Details on test material:
- Name: PC-9S
CAS Number: 1271738-25-0
Batch: PS101103
Physical Appearance: Off-white Powder
Purity: Over 99%
Melting Point: Approx. 95°C
Expiry Date: November 18, 2012
Storage Conditions: At room temperature (20+/- 5°C), avoid direct sun rays and extreme heat
Safety Precautions: Routine hygienic procedures
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- Test System: Mice, CBA/Ca
Source: Charles River Laboratories, Manston Road, Margate Kent CT9 4AL. United Kingdom crukcsd@crl.com
Age: 10-12 weeks at the beginning of treatment
Body Weight: 18.0 – 21.3 g at the beginning of treatment
Accommodation: Group housing in Makrolon Type-II cages with standard softwood bedding
Diet: Pelleted standard Harlan Teklad 2914C rodent maintenance diet (Provimi Kliba AG, 4303 Kaiseraugst/Switzerland), available ad libitum.
Water: Community tap water from Itingen/Switzerland, available ad libitum.
Environmental conditions:
Acclimatisation:
13 days prior to the start of the test under test conditions after health examination. Only animals with intact ears and without any visible signs of illness were used for the study.
Standard Laboratory Conditions. Air-conditioned with target ranges for room temperature 22 + /- 3 °C, relative humidity 30 - 70% and 10 - 15 air changes per hour. Room temperature and humidity was monitored continuously and values outside of these ranges may occasionally occur, usually following room cleaning. These transient variations were considered not to have any influence on the study and, therefore, these data were not reported but are retained at Harlan Laboratories Ltd. There was a 12 hour fluorescent light/12 hour dark cycle with at least 8 hours music during the light period.
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- Group concentration of test item (w/v) Number of animals per group Animal number
1 vehicle - 4 (1 - 4)
2 low dose 2.5 4 (5 - 8)
3 Mid dose 5 4 (9 - 12)
4 High dose 10 4 (13 - 16) - No. of animals per dose:
- 4
- Details on study design:
- A solubility experiment was performed according to the recommendations given by the guideline OECD 429. The highest test item concentration which can be technically used was a 10% (w/w) homogeneous suspension in DMF.
To determine the highest non-irritant test concentration, a pre-test was performed in two animals. Two mice were treated with concentrations of 5% and 10% (w/v) each in DMF on three consecutive days. In the pre-test clinical signs were recorded within approximately 1 hour and 24 ± 4 hours after each application as well as on the day corresponding to the day of lymph node preparation.
An erythema scoring was performed according to OECD guideline 429. Excessive local skin irritation is indicated by an erythema score ≥ 3. - Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
- Statistics:
- For the body weight mean values and standard deviations were calculated.
Results and discussion
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- SI
- Remarks on result:
- other: see Remark
- Remarks:
- In this study the stimulation index was calculated to be 0.9, 1.0 and 0.8 were determined with the test item, PC-9S, dissolved in DMF at concentrations of 2.5%, 5%, 10% (w/v), respectively. The EC3 value could not be calculated, since none of the tested concentrations induced a stimulation index greater than 3. Based on the test results, the test item PC-9S does not show an allergenic potential when tested up to the concentration of 10% (w/v) in DMF.
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: Not stated
Any other information on results incl. tables
Body weights:
The body weights of the animals, recorded at the start of acclimatization, prior to the first application and prior to sacrifice, were within the range commonly recorded for animals of the strain and age.
Clinical signs:
Neither clinical signs on the ears of the animals nor systemic findings were observed during the study period.
Mortality:
No deaths occurred during the study period.
Test item concentration (%) | S.I. | |
Group 1 | - | - |
Group 2 | 2.5 | 0.9 |
Group 3 | 5.0 | 0.9 |
Group 4 | 10.0 | 0.8 |
EC3 = --- |
||
A calculation of the EC3 value was not performed because no test concentrations produced a S.I. of 3 or higher. |
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- A test item is regarded as a sensitizer in the LLNA if the exposure to one or more test concentrations resulted in a 3-fold or greater increase in incorporation of 3HTdR compared with concurrent controls, as indicated by the S.I.
In this study S.I. of 0.9, 1.0 and 0.8 were determined with the test item, PC-9S, dissolved in DMF at concentrations of 2.5%, 5%, 10% (w/v), respectively.
The EC3 value could not be calculated, since none of the tested concentrations induced an S.I. greater than 3.
Based on the test results, the test item PC-9S does not show an allergenic potential when tested up to the concentration of 10% (w/v) in DMF. - Executive summary:
In order to study the possible contact allergenic potential of PC-9S, three groups of four female mice each were treated daily with the test item at concentrations of 2.5%, 5%, and 10% (w/v) in DMF by topical application to the dorsum of each ear lobe for three consecutive days. A control group of four female mice was treated with the vehicle DMF only. Five days after the first topical application the mice were injected intravenously into a tail vein with radio-labelled thymidine (3H-methyl thymidine, 3HTdR). Approximately five hours after intravenous injection, the mice were sacrificed, the draining auricular lymph nodes were excised and pooled per group. Single cell suspensions of lymph node cells were prepared from pooled lymph nodes which were subsequently washed and incubated with trichloroacetic acid overnight. The proliferative capacity of pooled lymph node cells was determined by the incorporation of 3HTdR measured in a β-scintillation counter. All treated animals survived the scheduled study period. Neither clinical signs on the ears of the animals nor systemic findings were observed during the study period. The results obtained [Stimulation Index (S.I.)] are reported in the following table:
Test item concentration (%) S.I. Group 1 - - Group 2 2.5 0.9 Group 3 5.0 0.9 Group 4 10.0 0.8 EC3 = ---
A calculation of the EC3 value was not performed because no test concentrations produced a S.I. of 3 or higher. The estimated concentration of test item required to produce a S.I. of 3 is referred to as the EC3 value.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.